Tue, Nov 25, 2014, 10:22 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

InVivo Therapeutics Holdings Corp. Message Board

factman777 16 posts  |  Last Activity: Nov 20, 2014 12:15 PM Member since: Oct 10, 2012
  • This point should not be taken lightly as one of the most important milestones for this company is to complete the 5 patient safety study and move on to scaffold+stems cells for acute SCI patients and then onto then holy grail (scaffold+stem cells for chronic SCI patients). They will have no trouble signing up chronic SCI patients. In fact, there will probably be a waiting list of patients to have the scaffold+stem cells implanted.

    Nov 4, 2014 Investor Presentation
    - "After 2 subjects have been safely implanted, InVivo plans to approach FDA regarding concurrent enrollment."

    Nov 19, 2014 Investor Presentation
    - "Negotiating with FDA regarding concurrent enrollment for subjects 3-5"

    Sentiment: Strong Buy

  • Reply to

    Should Gap up in the Morning

    by envy_vo Nov 12, 2014 3:57 PM
    factman777 factman777 Nov 12, 2014 4:22 PM Flag

    Hey envy_vo. Welcome back. Don't be a stranger.

    Here's one for old time sake...

    "Nobody owns enough of NVIV"

    Sentiment: Strong Buy

  • Here are the links:

    http://www.dailynews724.com/arizona/scottsdale-man-hopes-to-walk-again-after-groundbreaking-surgery-h304912.html

    http://www.azfamily.com/news/health/Scottsdale-man-hopes-to-walk-again-after-groundbreaking-surgery-282359021.html

    Don't be surprised if we soon see a takeover bidding war for Invivo.

    Sentiment: Strong Buy

  • Check it out...

    https://in.news.yahoo.com/rafael-nadal-undergo-stem-cell-123111125.html

    The stock should be at least $4.00 per share. There are two reasons for this ridiculously low price: the former CEO has been selling his shares in the open market due to a divorce settlement and several omission lies by this same former CEO who basically was kicked out of the company by the current BOD.

    Definitions of "Omission Lie":

    1. Also known as a continuing misrepresentation, a lie by omission occurs when an important fact is left out in order to foster a misconception. Lying by omission includes failures to correct pre-existing misconceptions.
    2, A lie of omission is an intentional failure to tell the truth in a situation requiring disclosure.

    This is still time to catch the InVivo train which could turn out to be a runaway train. I sure would hate to be short this stock..

    FWIW: dropping the first and last letter in INVIVO = NVIV !!!

    Sentiment: Strong Buy

  • https://finance.yahoo.com/news/barrow-neurosurgeons-implant-worlds-first-190000725.html

    Last chance to buy at this ridiculous low stock price.

    Sentiment: Strong Buy

  • Anyone know a free web site that list all the trades for a stock on a particular day?

    Thanks in advance,
    - FactMan777

    Sentiment: Strong Buy

  • Dr. Ulich's presentation will take place at 3:00PM PDT on Tuesday, October 7th at the Estancia La Jolla Hotel. A live video webcast of all company presentations will be available at: (See Press Release for URL) and will also be published on the Alliance for Regerative Medicine’s website shortly after the event.

    Sentiment: Strong Buy

  • FWIW...

    Someone is looking to buy/add to his/her position.

    Sentiment: Strong Buy

  • factman777 factman777 Sep 12, 2014 3:22 PM Flag

    The exercise of the warrants would extend the cash runway into 2017. Of course, the stock has to get above $1.43 for this to happen. Enrolling the first patient should do the trick.

    Sentiment: Strong Buy

  • factman777 by factman777 Sep 10, 2014 5:07 PM Flag

    Does anyone know how to get YAHOO Finance to pick this up article so it appears under Headlines?

    Sentiment: Strong Buy

  • Reply to

    "New" Investor presentation posted

    by alleg180 Sep 8, 2014 9:23 AM
    factman777 factman777 Sep 8, 2014 10:09 AM Flag

    They also added under:: Human pilot study on page 23

    the following:

    After 2 patients have been safely treated, InVivo plans to approach FDA about removing 3 month hold between patients

    Sentiment: Strong Buy

  • You seem to be the most informed and level headed poster on this board.

    What is your opinion on the total lack of insider buying? Do you think it is possible that since the Annual Shareholders meeting on July 30 that the company has been in a quiet period where insider buying is not permitted? I was at this meeting and McCarthy said the windows for insider buying have been small with all that had been going in with the company but the window for buying shares on the open market should be much larger going forward.

    Also, I believe a company should only reverse split their stock to maintain a listing on an exchange. Since NVIV is on the OTCBB there is no need to. Reverse splits almost always hurts shareholder value, especially with a company that has no revenues. Can you see a scenario why management would do a reverse split?

    Sentiment: Strong Buy

  • Reply to

    somethings gotta give....

    by flsh56 Sep 4, 2014 11:24 AM
    factman777 factman777 Sep 4, 2014 3:58 PM Flag

    No way they announce a reverse split now. Not for a company with no revenues. Reverse splits almost always hurts shareholder value. The only time a company should consider reverse splitting their stock is to maintain a listing on an exchange. They are on the OTCBB and do not need to reverse split their stock to stay on the OTCBB.

    Sentiment: Strong Buy

  • Reply to

    Question on SC 13D/A filed on Aug 29, 2014

    by factman777 Sep 4, 2014 3:44 PM
    factman777 factman777 Sep 4, 2014 3:49 PM Flag

    Answered my own question. The Schedule 13D states the following:

    The aggregate number of shares of Common Stock beneficially owned by the Reporting Persons is 6,945,699 as of the date of this Amendment No. 3. The aggregate number of shares of Common Stock beneficially owned by the Reporting Person represents a 7.4% ownership interest of the Company.

    Sentiment: Strong Buy

  • The Schedule 13D has Aug 7, 2014 as the “Date of Event which Requires Filing of this Statement”

    It states the Aggregate amount beneficially owned by each reporting person = 6,945,699.

    It also states from 8/8/2014 to 8/28/201 1,507,409 shares were sold by Frank.

    Does he have the following shares left: 6,945,699 - 1,507,409 = 5,438,290 ?
    Or does the 6,945,699.indicate the amount owned at the time of the filing?

    He originally acquired 15,147,600 shares on Oct 26, 2010.

    Sentiment: Strong Buy

  • First let me state that I am not a tax expert.

    Here is something that may be worth doing if you are holding you InVivo shares in a Tradiional IRA. Since the price is so low you may want to covert to a Roth IRA. Then if InVivo goes back up, you do not have to pay taxes on the gains when you withdraw at age 59 ½ or older. However, you will have to pay tax on the conversion amount for the tax year 2014. The good thing about this strategy is that if InVivo declines further you have until Oct 15, 2015 to undo the conversion which is called: re-characterization. If you undo the conversion then you do not have to pay taxes. It’s like you never converted in the first place. You then need to wait 30 days and then you can convert again if you wish.

    So let’s say you own 100,000 shares of InVivo. Your convert 33,000 shares at $0.63. You will have to pax taxes on $20,790. InVivo then drops to $0.50. You re-characterize the 33,000 shares. From the other 67,000 shares you then immediately convert 33,000 shares to a new Roth IRA at $0.50. Now you have to pay taxes only on the new conversion which is $16,500. The original conversion at $0.63 never happened. You have to make sure you keep each Roth conversion in its own new Roth IRA account so as to keep track of which shares can be re-characterize and if you have to wait 30 days to convert more shares after a re-characterization. My scenario describes the beginnings of how you could reduce the tax hit if InVivo falls further after conversion(s).

    Of course, you could convert all 100,000 shares and if InVivo goes up and you can handle the tax hit on $63,000 then you are good to go. If InVivo then went down you could re-characterize the100,000 shares. But then you have to wait 30 days to convert again and it could be just you luck that within those 30 days the first patient is enrolled and gets up and walks!
    Please Google: “Fidelity How to reverse a Roth IRA conversion” for more information on recharacteri

    Sentiment: Strong Buy

NVIV
1.25-0.05(-3.85%)Nov 25 3:59 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.